Trademark: 88408650
Status Date
Monday, November 23, 2020
Filing Date
Tuesday, April 30, 2019
Published for Opposition
Tuesday, August 27, 2019
Abandoned Date
Monday, November 23, 2020
5 Pharmaceutical oncology and neuroendocrine hormone preparations; Pharmaceutical preparations containing octreotide for the treatment of endocrine disorders and acromegaly
Nov 23, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 23, 2020
Abandonment - No Use Statement Filed
Apr 29, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 29, 2020
Teas Change Of Correspondence Received
Apr 29, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 29, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 29, 2020
Teas Change Of Owner Address Received
Nov 20, 2019
Notice Of Approval Of Extension Request E-Mailed
Nov 18, 2019
Extension 1 Granted
Nov 18, 2019
Extension 1 Filed
Nov 18, 2019
Teas Extension Received
Oct 22, 2019
Noa E-Mailed - Sou Required From Applicant
Aug 27, 2019
Official Gazette Publication Confirmation E-Mailed
Aug 27, 2019
Published For Opposition
Aug 7, 2019
Notification Of Notice Of Publication E-Mailed
Jul 19, 2019
Approved For Pub - Principal Register
Jul 12, 2019
Assigned To Examiner
May 16, 2019
New Application Office Supplied Data Entered In Tram
May 3, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
